AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • August 8th, 2013 • Pharmacyclics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 8th, 2013 Company Industry JurisdictionTHIS AMENDED AND RESTATED LICENSE AGREEMENT, is made and entered into as of June 28, 2013, (the “Amended and Restated Effective Date”), by Pharmacyclics, Inc., a Delaware corporation whose principal address is 995 East Arques Avenue, Sunnyvale, California 94085-4521 (“PCYC”), and Novo Nordisk Healthcare AG, a Swiss corporation whose principal address is Thurgauerstrasse 36/38, 8050 Zurich Switzerland (“Novo Nordisk”).
LICENSE AGREEMENTLicense Agreement • February 26th, 2013 • Pharmacyclics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 26th, 2013 Company Industry JurisdictionTHIS LICENSE AGREEMENT, is made and entered into as of October 4, 2012, (the “Effective Date”), by Pharmacyclics, Inc., a Delaware corporation whose principal address is 995 East Arques Avenue, Sunnyvale, California 94085-4521 (“PCYC”), and Novo Nordisk Healthcare AG, a Swiss corporation whose principal address is Thurgauerstrasse 36/38, 8050 Zurich Switzerland (“Novo Nordisk”).